7Baggers
 DMAC: Cantor Fitzgerald Initiates Coverage with Overweight Ratin  GuruFocus Fri, 14 Nov 2025 15:18:45 GMT
 DiaMedica Therapeutics Reports Q3 2025 Financial Results  TipRanks Fri, 14 Nov 2025 04:19:18 GMT
 DiaMedica Therapeutics’ Earnings Call: Mixed Outlook  TipRanks Fri, 14 Nov 2025 00:27:45 GMT
 DiaMedica Therapeutics Inc (DMAC) Q3 2025 Earnings Call Highligh  GuruFocus Thu, 13 Nov 2025 19:13:01 GMT
 DiaMedica Misses Earnings, But Analysts Still See Upside  Finimize Thu, 13 Nov 2025 00:01:46 GMT
 DiaMedica Therapeutics reports Q3 EPS (17c), consensus (16c)  TipRanks Wed, 12 Nov 2025 22:33:10 GMT
 DiaMedica (DMAC): Strong Cash Position Boosts Future Clinical Pl  GuruFocus Wed, 12 Nov 2025 21:58:30 GMT
 DiaMedica Therapeutics Inc. SEC 10-Q Report  TradingView Wed, 12 Nov 2025 21:40:41 GMT
 DiaMedica Therapeutics' Q3 net loss widens  TradingView Wed, 12 Nov 2025 21:40:00 GMT
 An Overview of DiaMedica Therapeutics's Earnings  Benzinga Tue, 11 Nov 2025 15:06:13 GMT
 published on: 2025-11-09 12:50:47  newser.com Sun, 09 Nov 2025 18:50:47 GMT
 DiaMedica Therapeutics Insiders Land Bargain With Gains Of US$26m  simplywall.st Fri, 07 Nov 2025 08:00:00 GMT
 published on: 2025-11-01 02:03:37  newser.com Sat, 01 Nov 2025 07:03:37 GMT
 published on: 2025-10-31 05:34:37  newser.com Fri, 31 Oct 2025 10:34:37 GMT
 diamedica therapeutics initiated with a buy at td cowen  TipRanks Thu, 30 Oct 2025 19:41:48 GMT

DiaMedica Therapeutics Inc
(NASDAQ:DMAC) 

DMAC stock logo

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. Its lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which has completed Phase Ib clinical trials for the treatment of patients with modera...

Founded: 2000
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends